DUX4 and facioscapulohumeral muscular dystrophy: To evaluate the functional contribution of MMPs to the dystrophic phenotype in DUX4-affected muscle, we tested the pan-MMP inhibitor batimastat in a model of acute, mild, DUX4-induced FSHD phenotype.